Edition:
United Kingdom

CTI Biopharma Corp (CTIC.OQ)

CTIC.OQ on NASDAQ Stock Exchange Capital Market

1.93USD
19 Oct 2018
Change (% chg)

$-0.06 (-3.02%)
Prev Close
$1.99
Open
$1.98
Day's High
$2.04
Day's Low
$1.92
Volume
42,553
Avg. Vol
165,512
52-wk High
$5.36
52-wk Low
$1.70

Chart for

About

CTI BioPharma Corp. (CTI), formerly Cell Therapeutics, Inc., is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers. The Company is focused on commercializing PIXUVRI... (more)

Overall

Beta: 0.62
Market Cap(Mil.): $140.98
Shares Outstanding(Mil.): 42.98
Dividend: --
Yield (%): --

Financials

  CTIC.OQ Industry Sector
P/E (TTM): -- 85.41 33.64
EPS (TTM): -1.80 -- --
ROI: -85.83 0.21 14.27
ROE: -127.14 1.17 15.99

BRIEF-Cti Biopharma Reports Q1 EPS Loss Per Share Of $0.08

* AS OF MARCH 31, 2018, CASH AND CASH EQUIVALENTS TOTALED $104.6 MILLION, COMPARED TO $43.2 MILLION AS OF DECEMBER 31, 2017 Source text for Eikon: Further company coverage:

03 May 2018

Earnings vs. Estimates